JP2015128593A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015128593A5 JP2015128593A5 JP2015002075A JP2015002075A JP2015128593A5 JP 2015128593 A5 JP2015128593 A5 JP 2015128593A5 JP 2015002075 A JP2015002075 A JP 2015002075A JP 2015002075 A JP2015002075 A JP 2015002075A JP 2015128593 A5 JP2015128593 A5 JP 2015128593A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- self
- amino acid
- peptidomimetic
- assembling peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 21
- 238000009472 formulation Methods 0.000 claims 20
- 125000000539 amino acid group Chemical group 0.000 claims 10
- 239000000816 peptidomimetic Substances 0.000 claims 8
- 210000001519 tissues Anatomy 0.000 claims 5
- 230000002209 hydrophobic Effects 0.000 claims 3
- 239000000463 material Substances 0.000 claims 3
- 239000011159 matrix material Substances 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 2
- 150000002500 ions Chemical class 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 230000001225 therapeutic Effects 0.000 claims 2
- 229940035676 ANALGESICS Drugs 0.000 claims 1
- 229940116904 ANTIINFLAMMATORY THERAPEUTIC RADIOPHARMACEUTICALS Drugs 0.000 claims 1
- 239000004475 Arginine Substances 0.000 claims 1
- 229960005261 Aspartic Acid Drugs 0.000 claims 1
- 229940039227 DIAGNOSTIC AGENTS Drugs 0.000 claims 1
- 229960002989 Glutamic Acid Drugs 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 229940074726 OPHTHALMOLOGIC ANTIINFLAMMATORY AGENTS Drugs 0.000 claims 1
- 229940074730 OPHTHAMOLOGIC DIAGNOSTIC AGENTS Drugs 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 150000001413 amino acids Chemical group 0.000 claims 1
- 230000000202 analgesic Effects 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011248 coating agent Substances 0.000 claims 1
- 238000000576 coating method Methods 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 238000011109 contamination Methods 0.000 claims 1
- 239000000032 diagnostic agent Substances 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 230000001264 neutralization Effects 0.000 claims 1
- 235000016709 nutrition Nutrition 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000005526 vasoconstrictor agent Substances 0.000 claims 1
Claims (17)
- 6〜200個のアミノ酸残基の長さを有する自己集合ペプチドまたはそのペプチド模倣物を含む処方物であって、
前記自己集合ペプチドまたはペプチド模倣物は、組織特異的成分および/または疎水性尾部をさらに含み、
前記組織特異的成分および/または疎水性尾部は、前記ペプチドまたはペプチド模倣物を特異的細胞型または組織型に標的化し、または特異的細胞型または組織型に結合させ、
前記処方物は5mM未満の濃度のイオンを含み、
前記自己集合ペプチドまたはペプチド模倣物の濃度は、5mMを超える濃度のイオンへの曝露により、体液の移動および/または汚染に対するバリア形成に有効である、前記処方物。 - 前記自己集合ペプチドが、式IIIまたは式IVに適合するアミノ酸残基の配列を含む、請求項2に記載の処方物。
- Xaaneuがアラニンを表し、Xaa+がアルギニンまたはリジンを表し、そしてXaa−がアスパラギン酸またはグルタミン酸を表す、請求項3に記載の処方物。
- 前記アミノ酸残基が、天然に存在するアミノ酸残基を含む、請求項2に記載の処方物。
- 前記アミノ酸残基が、天然由来ではないアミノ酸残基である、請求項2に記載の処方物。
- 前記自己集合物質が、ペプチド模倣物である、請求項6に記載の処方物。
- 前記ペプチド模倣物が、α−ペプチド、β−ペプチド、γ−ペプチド、δ−ペプチド、およびらせんまたはシート構造を取りえるバックボーンを有するオリゴマーからなる群より選択される、請求項7に記載の処方物。
- 自己集合ペプチドまたは自己集合ペプチド模倣物の濃度が、0.1%〜99%である、請求項1〜8のいずれか一項に記載の処方物。
- 身体上もしくは身体中への投与のための薬学的に許容される担体またはマトリックスまたは支持物質をさらに含む、請求項1〜9のいずれか一項に記載の処方物。
- 前記薬学的に許容される担体またはマトリックスまたは支持物質が、医療装置もしくは移植片上のコーティングとして、または重合体のマトリックス、ヒドロゲル、布、縫糸、もしくはスポンジ中に取り込まれる、乾燥粉末、液体、懸濁物および溶液からなる群より選択される、請求項10に記載の処方物。
- 0.5% v/w〜5.0% v/wの自己集合ペプチド濃度を有する液体である、請求項1〜11のいずれか一項に記載の処方物。
- 一つ以上の治療薬、予防薬、診断薬または細胞をさらに含む、請求項1〜12のいずれか一項に記載の処方物。
- 一つ以上の治療薬、予防薬または診断薬が、血管収縮薬、着色薬、鎮痛剤、抗微生物薬、抗炎症薬、成長因子、栄養薬およびそれらの組合せからなる群より選択される、請求項13に記載の処方物。
- 自己集合ペプチドまたはそのペプチド模倣物が、配列番号1〜59からなる群より選択される、請求項1〜14のいずれか一項に記載の処方物。
- 組織特異的成分および/または疎水性尾部が、配列番号126〜409からなる群より選択される、請求項1〜15に記載の処方物。
- 自己集合ペプチドまたはそのペプチド模倣物が、配列番号60〜125からなる群より選択される1つ以上の付加的アミノ酸配列をさらに含む、請求項1〜15に記載の処方物。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/740,284 | 2007-04-25 | ||
US11/740,284 US9162005B2 (en) | 2005-04-25 | 2007-04-25 | Compositions for prevention of adhesions and other barrier applications |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010506529A Division JP5976272B2 (ja) | 2007-04-25 | 2008-04-25 | 癒着の予防および他のバリア適用のための組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017048126A Division JP6441978B2 (ja) | 2007-04-25 | 2017-03-14 | 癒着の予防および他のバリア適用のための組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2015128593A JP2015128593A (ja) | 2015-07-16 |
JP2015128593A5 true JP2015128593A5 (ja) | 2015-11-26 |
JP6113764B2 JP6113764B2 (ja) | 2017-04-12 |
Family
ID=39620203
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010506529A Active JP5976272B2 (ja) | 2007-04-25 | 2008-04-25 | 癒着の予防および他のバリア適用のための組成物 |
JP2015002075A Active JP6113764B2 (ja) | 2007-04-25 | 2015-01-08 | 癒着の予防および他のバリア適用のための組成物 |
JP2017048126A Active JP6441978B2 (ja) | 2007-04-25 | 2017-03-14 | 癒着の予防および他のバリア適用のための組成物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010506529A Active JP5976272B2 (ja) | 2007-04-25 | 2008-04-25 | 癒着の予防および他のバリア適用のための組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017048126A Active JP6441978B2 (ja) | 2007-04-25 | 2017-03-14 | 癒着の予防および他のバリア適用のための組成物 |
Country Status (9)
Country | Link |
---|---|
US (3) | US9162005B2 (ja) |
EP (2) | EP2581097B1 (ja) |
JP (3) | JP5976272B2 (ja) |
CA (1) | CA2722465C (ja) |
DK (1) | DK2581097T3 (ja) |
ES (1) | ES2639625T3 (ja) |
HU (1) | HUE034194T2 (ja) |
PL (1) | PL2581097T3 (ja) |
WO (1) | WO2008134544A1 (ja) |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5255274B2 (ja) * | 2004-07-06 | 2013-08-07 | スリーディー マトリックス, インコーポレイテッド | 精製両親媒性ペプチド組成物およびその使用 |
EP2283851B1 (en) | 2005-04-25 | 2023-06-07 | Massachusetts Institute of Technology | Compositions for promoting hemostasis |
US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
US20160045457A1 (en) | 2005-09-09 | 2016-02-18 | Ousama Rachid | Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine |
US9877921B2 (en) * | 2005-09-09 | 2018-01-30 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
WO2011109340A1 (en) | 2010-03-01 | 2011-09-09 | Nova Southeastern University | Epinephrine nanop articles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
ES2397441T5 (es) | 2006-02-13 | 2022-09-14 | Daiichi Sankyo Co Ltd | Secuencias polinucleotídicas y polipeptídicas implicadas en el proceso de remodelación ósea |
US9084837B2 (en) | 2006-04-25 | 2015-07-21 | Massachusetts Institute Of Technology | Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions |
CA2680824C (en) * | 2007-03-14 | 2018-06-26 | Arch Therapeutics, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
US7906478B2 (en) * | 2007-07-20 | 2011-03-15 | The Procter & Gamble Company | Personal-care articles having self-assembling peptides |
GB0722820D0 (en) | 2007-11-21 | 2008-01-02 | Smith & Nephew | Vacuum assisted wound dressing |
US8808259B2 (en) | 2007-11-21 | 2014-08-19 | T.J. Smith & Nephew Limited | Suction device and dressing |
HUE041864T2 (hu) | 2007-11-21 | 2019-06-28 | Smith & Nephew | Sebkötözõ |
US20110002880A1 (en) * | 2007-12-05 | 2011-01-06 | 3-D Matrix, Ltd. | Material For Wound Healing and Skin Reconstruction |
US11253399B2 (en) | 2007-12-06 | 2022-02-22 | Smith & Nephew Plc | Wound filling apparatuses and methods |
GB0723875D0 (en) | 2007-12-06 | 2008-01-16 | Smith & Nephew | Wound management |
GB0803564D0 (en) | 2008-02-27 | 2008-04-02 | Smith & Nephew | Fluid collection |
GB0808376D0 (en) | 2008-05-08 | 2008-06-18 | Bristol Myers Squibb Co | Wound dressing |
US9023376B2 (en) * | 2008-06-27 | 2015-05-05 | The University Of Akron | Nanofiber-reinforced composition for application to surgical wounds |
GB0817796D0 (en) | 2008-09-29 | 2008-11-05 | Convatec Inc | wound dressing |
WO2010041636A1 (ja) * | 2008-10-06 | 2010-04-15 | 株式会社スリー・ディー・マトリックス | 組織閉塞剤 |
US9439941B2 (en) | 2009-12-14 | 2016-09-13 | The University Of Hong Kong | Nano cancer barrier device (NCBD) to immobilize and inhibit the division of metastic cancer stem cells |
US9061095B2 (en) | 2010-04-27 | 2015-06-23 | Smith & Nephew Plc | Wound dressing and method of use |
GB201011173D0 (en) | 2010-07-02 | 2010-08-18 | Smith & Nephew | Provision of wound filler |
JP2013538864A (ja) * | 2010-10-08 | 2013-10-17 | ソルヴェイ(ソシエテ アノニム) | 生物活性アミノ酸配列及びその使用 |
MX337627B (es) | 2010-11-25 | 2016-03-10 | Smith & Nephew | Composiciones i-ii y productos y usos de la misma. |
GB201020005D0 (en) | 2010-11-25 | 2011-01-12 | Smith & Nephew | Composition 1-1 |
GB201020236D0 (en) | 2010-11-30 | 2011-01-12 | Convatec Technologies Inc | A composition for detecting biofilms on viable tissues |
CA2819475C (en) | 2010-12-08 | 2019-02-12 | Convatec Technologies Inc. | Integrated system for assessing wound exudates |
CA2819549C (en) | 2010-12-08 | 2019-09-10 | Convatec Technologies Inc. | Wound exudate system accessory |
US8546338B2 (en) | 2010-12-08 | 2013-10-01 | Johnson & Johnson Consumer Companies, Inc. | Self-assembling hydrogels based on dicephalic peptide amphiphiles |
GB201115182D0 (en) | 2011-09-02 | 2011-10-19 | Trio Healthcare Ltd | Skin contact material |
CA2853084C (en) * | 2011-10-21 | 2022-04-26 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
WO2013071049A1 (en) * | 2011-11-10 | 2013-05-16 | Trustees Of Boston College | Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity |
US20150159066A1 (en) | 2011-11-25 | 2015-06-11 | Smith & Nephew Plc | Composition, apparatus, kit and method and uses thereof |
GB2497406A (en) | 2011-11-29 | 2013-06-12 | Webtec Converting Llc | Dressing with a perforated binder layer |
GB201120693D0 (en) | 2011-12-01 | 2012-01-11 | Convatec Technologies Inc | Wound dressing for use in vacuum therapy |
KR101345333B1 (ko) | 2011-12-30 | 2013-12-30 | 조선대학교산학협력단 | 라이신 및 트립토판 잔기가 4번 반복된 신규한 항균 및 항진균 펩타이드 및 이의 용도 |
CA3169368A1 (en) | 2012-06-15 | 2014-01-09 | Nova Southeastern University | Epinephrine nanoparticles, methods of fabrication thereof, and methods for use thereof for treatment of conditions responsive to epinephrine |
EP3466964A1 (en) | 2012-07-06 | 2019-04-10 | 3-D Matrix Ltd. | Fill-finish process for peptide solutions |
EA201590247A1 (ru) | 2012-07-19 | 2015-10-30 | Алетиа Байотерапьютикс Инк. | Антитела к siglec-15 |
EP2885015B1 (en) | 2012-08-17 | 2022-09-28 | AMSilk GmbH | Use of self-assembling polypeptides as tissue adhesives |
CN105008611A (zh) | 2012-12-20 | 2015-10-28 | 康沃特克科技公司 | 化学改性的纤维素纤维的处理 |
EP2968693B1 (en) * | 2013-03-14 | 2022-06-01 | 3-D Matrix, Ltd. | Materials for gastrointestinal obstruction prevention |
US20160120706A1 (en) | 2013-03-15 | 2016-05-05 | Smith & Nephew Plc | Wound dressing sealant and use thereof |
EP2976072B9 (en) | 2013-03-22 | 2021-10-13 | Nova Southeastern University | Epinephrine fine particles and methods for use thereof for treatment of conditions responsive to epinephrine |
DE102013211316A1 (de) * | 2013-06-17 | 2014-12-18 | Aesculap Ag | Hämostyptikum |
CA2921505C (en) | 2013-08-22 | 2018-05-22 | Arch Biosurgery, Inc. | Implantable meshes for controlling the movement of fluids |
AU2015229549B2 (en) | 2014-03-10 | 2019-05-23 | 3-D Matrix, Ltd. | Self-assembling peptide compositions |
WO2015138478A1 (en) | 2014-03-10 | 2015-09-17 | 3-D Matrix, Ltd. | Autoassembling peptides for the treatment of pulmonary bulla |
ES2927887T3 (es) | 2014-03-10 | 2022-11-11 | 3 D Matrix Ltd | Esterilización de composiciones peptídicas |
EP3389734B1 (en) * | 2015-12-15 | 2021-06-23 | 3-D Matrix, Ltd | Self-assembling peptides comprising non-ionic polar amino acids for anti-adhesion |
WO2017120092A1 (en) | 2016-01-06 | 2017-07-13 | 3-D Matrix, Ltd. | Combination compositions |
MX2018011121A (es) * | 2016-03-18 | 2019-01-31 | 3 D Matrix Ltd | Prevención de la adherencia de tejido biológico. |
JP2019508181A (ja) * | 2016-03-18 | 2019-03-28 | 株式会社スリー・ディー・マトリックス | 脳脊髄液の漏出の閉鎖 |
WO2017173069A1 (en) | 2016-03-30 | 2017-10-05 | Convatec Technologies Inc. | Detecting microbial infections in wounds |
BR112018070238A2 (pt) | 2016-03-30 | 2019-01-29 | Acib Gmbh | detecção de infecção microbiana em feridas |
CN109996553A (zh) * | 2016-06-27 | 2019-07-09 | 立美基股份有限公司 | 用于在内窥镜剥离术后预防食管狭窄的自组装肽基质 |
EP3481360B1 (en) | 2016-07-08 | 2022-03-09 | ConvaTec Technologies Inc. | Fluid flow sensing |
EP3871645B1 (en) | 2016-07-08 | 2022-05-04 | ConvaTec Technologies Inc. | Flexible negative pressure system |
JP2019525799A (ja) | 2016-07-08 | 2019-09-12 | コンバテック・テクノロジーズ・インコーポレイテッドConvatec Technologies Inc | 流体収集装置 |
US10463760B2 (en) | 2017-10-31 | 2019-11-05 | InMEDBio, LLC | Absorbent, breathable and pathogen blocking/killing wound care dressing and fabrication thereof |
EP3723726A1 (en) | 2017-12-15 | 2020-10-21 | 3-D Matrix, Ltd. | Surfactant peptide nanostructures and uses in drug delivery |
CN112165952A (zh) | 2018-03-23 | 2021-01-01 | 阿奇生物外科有限公司 | 用于减轻炎症症状的sap和拟肽组合物 |
US20190292223A1 (en) * | 2018-03-23 | 2019-09-26 | Arch Biosurgery, Inc. | Sap and peptidomimetics for treatment of eye disease |
US20210220429A1 (en) * | 2018-10-05 | 2021-07-22 | Kurume University | Pharmaceutical composition for treating or preventing ulcer or fistula in intestinal tract |
CN109513044B (zh) * | 2019-01-29 | 2022-02-18 | 北京颢美细胞基因生物技术有限公司 | 用于微整形的再生组织基质微粒植入剂、制备方法及应用 |
CN113661427A (zh) * | 2019-04-09 | 2021-11-16 | 富士胶片株式会社 | 内窥镜用交联体、内窥镜以及用于形成内窥镜用交联体的组合物 |
US11331221B2 (en) | 2019-12-27 | 2022-05-17 | Convatec Limited | Negative pressure wound dressing |
US11771819B2 (en) | 2019-12-27 | 2023-10-03 | Convatec Limited | Low profile filter devices suitable for use in negative pressure wound therapy systems |
US20210213161A1 (en) | 2020-01-13 | 2021-07-15 | Arch Biosurgery, Inc. | Self-assembling peptide gel formulation and methods of use |
WO2023108026A2 (en) * | 2021-12-08 | 2023-06-15 | Oakgrove Bio Llc | Biological production of histidine-rich peptides |
CN116789854B (zh) * | 2023-06-08 | 2024-04-02 | 东北农业大学 | 兼具细菌捕获与抑菌功能的纳米抗菌肽及制备方法和应用 |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4098728A (en) * | 1976-01-02 | 1978-07-04 | Solomon Rosenblatt | Medical surgical sponge and method of making same |
US4211227A (en) * | 1978-07-03 | 1980-07-08 | The Kendall Company | Surgical sponge material |
US4272398A (en) * | 1978-08-17 | 1981-06-09 | The United States Of America As Represented By The Secretary Of Agriculture | Microencapsulation process |
US4636208A (en) * | 1984-10-05 | 1987-01-13 | Ewald Rath | Surgical sponge |
US4829000A (en) | 1985-08-30 | 1989-05-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Reconstituted basement membrane complex with biological activity |
US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US5019646A (en) | 1987-08-25 | 1991-05-28 | Regents Of The University Of Minnesota | Polypeptides with fibronectin activity |
US5843156A (en) | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
CA2122041A1 (en) * | 1989-12-04 | 1993-04-29 | Kenneth Kensey | Plug device for sealing openings and method of use |
US5180375A (en) * | 1991-05-02 | 1993-01-19 | Feibus Miriam H | Woven surgical drain and woven surgical sponge |
US5222974A (en) * | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5670483A (en) * | 1992-12-28 | 1997-09-23 | Massachusetts Insititute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US5955343A (en) * | 1992-12-28 | 1999-09-21 | Massachusetts Institute Of Technology | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
US5645565A (en) * | 1995-06-13 | 1997-07-08 | Ethicon Endo-Surgery, Inc. | Surgical plug |
US5762846A (en) | 1996-12-20 | 1998-06-09 | E. I. Du Pont De Nemours And Company | Dispersion spinning process for polytetrafluoroethylene and related polymers |
US6368877B1 (en) * | 1997-06-25 | 2002-04-09 | Massachusetts Institute Of Technology | Self-assembling peptide surfaces for cell patterning and interactions |
US5956343A (en) | 1997-12-23 | 1999-09-21 | Alcatel Usa Sourcing L.P. | Designating a control channel in a telecommunications system |
US6235340B1 (en) | 1998-04-10 | 2001-05-22 | Massachusetts Institute Of Technology | Biopolymer-resistant coatings |
US6333194B1 (en) * | 1999-01-19 | 2001-12-25 | The Children's Hospital Of Philadelphia | Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof |
WO2000063079A1 (en) * | 1999-04-15 | 2000-10-26 | Ultracell Medical Technologies Of Connecticut, Inc. | Method for producing surgical sponge device and product thereof |
US6844324B1 (en) * | 1999-11-12 | 2005-01-18 | Massachusetts Institute Of Technology | Modular peptide mediated intracellular delivery system and uses therefore |
US6953659B2 (en) * | 2000-07-14 | 2005-10-11 | Massachusetts Institute Of Technology | Direct, externally imposed control of nucleic acids |
US6953656B2 (en) | 2000-07-14 | 2005-10-11 | Massachusetts Institute Of Technology | Direct, externally imposed control of polypeptides |
US6846319B2 (en) * | 2000-12-14 | 2005-01-25 | Core Medical, Inc. | Devices for sealing openings through tissue and apparatus and methods for delivering them |
ES2325531T3 (es) * | 2001-01-31 | 2009-09-08 | Asahi Glass Company, Limited | Proceso para producir un compuesto de fluor. |
ATE419333T1 (de) | 2001-02-06 | 2009-01-15 | Massachusetts Inst Technology | Peptidgerüstverkapselung von gewebszellen und verwendungen davon |
US7449180B2 (en) * | 2001-02-06 | 2008-11-11 | John Kisiday | Macroscopic scaffold containing amphiphilic peptides encapsulating cells |
BR0209434A (pt) * | 2001-05-04 | 2006-02-07 | Scripps Research Inst | Peptìdeos antimicrobianos e composições |
US7179784B2 (en) * | 2001-07-10 | 2007-02-20 | Massachusetts Institute Of Technology | Surfactant peptide nanostructures, and uses thereof |
AU2002365077A1 (en) * | 2001-09-19 | 2003-06-30 | Massachusetts Institute Of Technology | Methods and products related to non-viral transfection |
WO2003084980A2 (en) | 2002-04-02 | 2003-10-16 | Northwestern University | Peptide amphiphile solutions and self assembled peptide nanofiber networks |
US20040242469A1 (en) | 2002-05-13 | 2004-12-02 | Lee Richard T. | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof |
CA2387257C (en) * | 2002-05-23 | 2009-07-28 | Suncor Energy Inc. | Static deaeration conditioner for processing of bitumen froth |
GB0216286D0 (en) | 2002-07-15 | 2002-08-21 | Univ Leeds | Network |
WO2004013161A2 (en) * | 2002-08-06 | 2004-02-12 | Epix Pharmaceuticals, Inc. | Peptide aggregates |
MXPA05008483A (es) | 2003-02-11 | 2006-03-10 | Univ Northwestern | Metodos y materiales para revestimientos de superficie nanocristalinos y union de nanofibras de anfililos peptidicos sobre las mismas. |
WO2004110964A2 (en) * | 2003-06-16 | 2004-12-23 | Nuevolution A/S | Encoded molecules by translation (emt) |
WO2005014615A2 (en) | 2003-06-25 | 2005-02-17 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
US7713923B2 (en) * | 2003-06-25 | 2010-05-11 | Massachusetts Institute Of Technology | Self-assembling peptides incorporating modifications and methods of use thereof |
US7846891B2 (en) * | 2003-10-17 | 2010-12-07 | Massachusetts Institute Of Technology | Self-assembling peptides for regeneration and repair of neural tissue |
US7704740B2 (en) | 2003-11-05 | 2010-04-27 | Michigan State University | Nanofibrillar structure and applications including cell and tissue culture |
AU2004296181A1 (en) * | 2003-12-05 | 2005-06-23 | Northwestern University | Self-assembling peptide amphiphiles and related methods for growth factor delivery |
GB0413346D0 (en) | 2004-06-15 | 2004-07-21 | Theryte Ltd | Treating cancer |
JP5255274B2 (ja) * | 2004-07-06 | 2013-08-07 | スリーディー マトリックス, インコーポレイテッド | 精製両親媒性ペプチド組成物およびその使用 |
US7884185B2 (en) * | 2004-07-28 | 2011-02-08 | University Of Delaware | Hydrogels and uses thereof |
WO2006013552A2 (en) | 2004-08-02 | 2006-02-09 | Ramot At Tel Aviv University Ltd. | Articles of peptide nanostructures and method of forming the same |
US8039258B2 (en) | 2004-09-28 | 2011-10-18 | Ethicon, Inc. | Tissue-engineering scaffolds containing self-assembled-peptide hydrogels |
WO2006047315A2 (en) * | 2004-10-25 | 2006-05-04 | The Brigham And Women's Hospital, Inc. | Targeted delivery of biological factors using self-assembling peptide nanofibers |
AU2005323062A1 (en) * | 2005-01-04 | 2006-07-13 | The Brigham And Women's Hospital, Inc. | Sustained delivery of PDGF using self-assembling peptide nanofibers |
EP2283851B1 (en) | 2005-04-25 | 2023-06-07 | Massachusetts Institute of Technology | Compositions for promoting hemostasis |
US9162005B2 (en) | 2005-04-25 | 2015-10-20 | Arch Biosurgery, Inc. | Compositions for prevention of adhesions and other barrier applications |
US8420605B2 (en) | 2005-09-07 | 2013-04-16 | The University Of Strathclyde | Hydrogel compositions |
US9084837B2 (en) | 2006-04-25 | 2015-07-21 | Massachusetts Institute Of Technology | Compositions and methods for affecting movement of contaminants, bodily fluids or other entities, and/or affecting other physiological conditions |
US20070287741A1 (en) * | 2006-06-13 | 2007-12-13 | Uri Herzberg | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
US8021570B2 (en) * | 2006-06-13 | 2011-09-20 | Wisconsin Alumni Research Foundation | β-peptide lyotropic liquid crystals and methods of manufacture and use thereof |
CA2680824C (en) * | 2007-03-14 | 2018-06-26 | Arch Therapeutics, Inc. | Treatment of leaky or damaged tight junctions and enhancing extracellular matrix |
US20110002880A1 (en) | 2007-12-05 | 2011-01-06 | 3-D Matrix, Ltd. | Material For Wound Healing and Skin Reconstruction |
WO2010041636A1 (ja) | 2008-10-06 | 2010-04-15 | 株式会社スリー・ディー・マトリックス | 組織閉塞剤 |
US8512728B2 (en) | 2009-02-21 | 2013-08-20 | Sofradim Production | Method of forming a medical device on biological tissue |
US20120085262A1 (en) | 2010-08-26 | 2012-04-12 | Freudenberg Forschungsdienste Kg | Production of Highly Concentrated Solutions of Self-Assembling Proteins |
TW201315479A (zh) | 2011-10-12 | 2013-04-16 | Univ Nat Cheng Kung | 可促進動脈新生之醫藥組成物、及其製備方法與應用 |
US20150218252A1 (en) | 2012-06-20 | 2015-08-06 | President And Fellows Of Harvard College | Self-assembling peptides, peptide nanostructures and uses thereof |
US9120841B2 (en) | 2012-09-28 | 2015-09-01 | Agency For Science, Technology And Research | Amphiphilic linear peptidepeptoid and hydrogel comprising the same |
CA2921505C (en) | 2013-08-22 | 2018-05-22 | Arch Biosurgery, Inc. | Implantable meshes for controlling the movement of fluids |
-
2007
- 2007-04-25 US US11/740,284 patent/US9162005B2/en active Active
-
2008
- 2008-04-25 DK DK12196176.7T patent/DK2581097T3/en active
- 2008-04-25 ES ES12196176.7T patent/ES2639625T3/es active Active
- 2008-04-25 EP EP12196176.7A patent/EP2581097B1/en not_active Revoked
- 2008-04-25 PL PL12196176T patent/PL2581097T3/pl unknown
- 2008-04-25 CA CA2722465A patent/CA2722465C/en active Active
- 2008-04-25 WO PCT/US2008/061622 patent/WO2008134544A1/en active Search and Examination
- 2008-04-25 EP EP08746940A patent/EP2150268A1/en not_active Ceased
- 2008-04-25 HU HUE12196176A patent/HUE034194T2/en unknown
- 2008-04-25 JP JP2010506529A patent/JP5976272B2/ja active Active
-
2015
- 2015-01-08 JP JP2015002075A patent/JP6113764B2/ja active Active
- 2015-10-16 US US14/885,673 patent/US9789157B2/en active Active
-
2017
- 2017-03-14 JP JP2017048126A patent/JP6441978B2/ja active Active
- 2017-09-26 US US15/716,262 patent/US10682386B2/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2015128593A5 (ja) | ||
JP2008505919A5 (ja) | ||
JP2008514586A5 (ja) | ||
Guo et al. | Fabrication of silver-incorporated TiO2 nanotubes and evaluation on its antibacterial activity | |
EP2567971A3 (en) | Peptide vaccines comprising Seq Id 80, 100 or 101 for cancers expressing tumor-associated antigens | |
CN1125400A (zh) | 九肽和十肽在治疗爱滋病药物的制备中的应用 | |
JP2019505486A5 (ja) | ||
RU2019126232A (ru) | Пептиды и способы для лечения диабета | |
JP2018519366A5 (ja) | ||
JP2015504073A5 (ja) | ||
JP2004537581A5 (ja) | ||
RU2016130448A (ru) | Пептидные дендримеры, содержащие фибриноген-связывающие пептиды | |
JP2021504448A5 (ja) | ||
JP2019523260A5 (ja) | ||
JP2014504601A5 (ja) | ||
HRP20211627T1 (hr) | Farmaceutski pripravak koji se sastoji od agonista receptora čimbenika rasta i proteina inhibitora adhezije za pretvaranje neoplastične stanice u neneoplastičnu stanicu i njegova upotreba | |
Vercellino et al. | Lingual thyroid imaging with I SPECT/CT. | |
JP2006523608A5 (ja) | ||
JP2019535707A5 (ja) | ||
JP2018509395A5 (ja) | ||
JP2019520336A5 (ja) | ||
JP2015524808A5 (ja) | ||
US11510985B2 (en) | Oral composition for delivery of drugs and other substances | |
AU2020302077C1 (en) | Compositions and methods for treatment of fungal infections | |
RU2013113677A (ru) | Визуализирующие апоптоз агенты на основе лантибиотических пептидов |